Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

SHE:300039 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,496	6,464	6,956	8,431	6,443	5,094
Market Cap Growth	-7.73%	-7.07%	-17.49%	30.84%	26.49%	-2.79%
Enterprise Value	4,861	5,145	6,224	6,828	5,042	3,721
Last Close Price	6.21	6.05	6.40	7.69	5.83	4.58
PE Ratio	18.80	17.21	21.22	44.19	45.99	48.00
Forward PE	-	24.15	24.15	24.15	24.15	24.15
PS Ratio	5.55	4.39	4.36	7.54	5.86	5.61
PB Ratio	1.43	1.58	1.73	2.24	2.12	1.98
P/TBV Ratio	1.48	1.64	1.75	2.27	2.16	2.03
P/FCF Ratio	32.21	46.70	19.67	24.45	77.14	21.52
P/OCF Ratio	29.32	23.17	18.18	22.40	51.11	20.32
PEG Ratio	-	0.97	0.97	0.97	0.97	0.97
EV/Sales Ratio	4.15	3.49	3.91	6.10	4.58	4.10
EV/EBITDA Ratio	14.19	13.18	17.92	32.02	32.91	30.80
EV/EBIT Ratio	15.75	14.50	20.09	37.62	42.25	46.51
EV/FCF Ratio	24.10	37.17	17.60	19.80	60.36	15.72
Debt / Equity Ratio	0.00	0.00	-	-	-	0.01
Debt / EBITDA Ratio	0.01	0.01	-	-	-	0.30
Debt / FCF Ratio	0.02	0.04	-	-	-	0.15
Asset Turnover	0.25	0.32	0.36	0.29	0.35	0.32
Inventory Turnover	1.14	1.52	1.88	1.52	1.31	0.95
Quick Ratio	11.07	9.49	3.86	4.72	10.85	8.50
Current Ratio	12.39	10.40	4.41	5.32	11.82	9.35
Return on Equity (ROE)	8.21%	9.22%	8.39%	5.59%	4.98%	4.12%
Return on Assets (ROA)	4.15%	4.88%	4.38%	2.98%	2.39%	1.75%
Return on Invested Capital (ROIC)	10.13%	10.76%	8.50%	6.75%	7.18%	5.35%
Return on Capital Employed (ROCE)	6.50%	8.30%	7.30%	4.60%	3.80%	3.00%
Earnings Yield	5.32%	5.81%	4.71%	2.26%	2.17%	2.08%
FCF Yield	3.10%	2.14%	5.08%	4.09%	1.30%	4.65%
Dividend Yield	0.98%	1.65%	1.56%	0.78%	0.86%	0.66%
Payout Ratio	30.28%	27.85%	19.14%	27.41%	22.59%	98.56%
Buyback Yield / Dilution	0.01%	-0.00%	0.02%	-0.01%	-0.04%	1.31%
Total Shareholder Return	0.97%	1.65%	1.59%	0.77%	0.81%	1.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.